Literature DB >> 16261603

Molecular pathogenesis of anemia of chronic disease.

Tomas Ganz1.   

Abstract

Most patients suffering from chronic infections, chronic inflammatory diseases, and some malignancies develop a mild to moderate anemia designated anemia of chronic disease or anemia of inflammation. Patients with this anemia have low serum iron, low to normal transferrin, and high to normal serum ferritin concentration. The anemia is caused by increased inflammatory cytokines, especially IL-6, inducing increased production of the iron-regulatory hormone hepcidin by hepatocytes. Hepcidin blocks the release of iron from macrophages, hepatocytes, and enterocytes, causing the characteristic hypoferremia associated with this anemia and iron-deprivation of the developing erythrocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16261603     DOI: 10.1002/pbc.20656

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  28 in total

1.  Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1.

Authors:  Gregory C Davenport; Collins Ouma; James B Hittner; Tom Were; Yamo Ouma; John M Ong'echa; Douglas J Perkins
Journal:  Am J Hematol       Date:  2010-04       Impact factor: 10.047

2.  Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.

Authors:  Ahmed Maher Kaddah; Amina Abdel-Salam; Marwa Salah Farhan; Reham Ragab
Journal:  Indian J Pediatr       Date:  2017-06-10       Impact factor: 1.967

3.  Time-of-flight mass spectrometry analysis of the ferroportin-hepcidin binding domain complex for accurate mass confirmation of bioactive hepcidin 25.

Authors:  David K Crockett; Mark M Kushnir; John D Phillips; Alan L Rockwood
Journal:  Clin Chim Acta       Date:  2009-12-03       Impact factor: 3.786

4.  A precious metal: Iron, an essential nutrient for all cells.

Authors:  G Cairo; F Bernuzzi; S Recalcati
Journal:  Genes Nutr       Date:  2006-03       Impact factor: 5.523

5.  Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease.

Authors:  Nilesh R Ghugre; Ignacio Gonzalez-Gomez; Ellen Butensky; Leila Noetzli; Roland Fischer; Roger Williams; Paul Harmatz; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2009-08       Impact factor: 10.047

Review 6.  Iron in multiple myeloma.

Authors:  Kristina VanderWall; Tracy R Daniels-Wells; Manuel Penichet; Alan Lichtenstein
Journal:  Crit Rev Oncog       Date:  2013

7.  Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo.

Authors:  Shan Soe-Lin; Sameer S Apte; Billy Andriopoulos; Marc C Andrews; Matthias Schranzhofer; Tanya Kahawita; Daniel Garcia-Santos; Prem Ponka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

8.  [Anemia in patients with rheumatoid arthritis].

Authors:  M Wahle
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

9.  Relationship between hepcidin levels and periodic limb movement disorder in patients with obstructive sleep apnea syndrome.

Authors:  Ozlem Abakay; Abdurrahman Abakay; Yilmaz Palanci; Hatice Yuksel; Hadice Selimoglu Sen; Osman Evliyaoglu; Abdullah Cetin Tanrikulu
Journal:  Sleep Breath       Date:  2014-07-10       Impact factor: 2.816

10.  Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.

Authors:  Elizabeta Nemeth
Journal:  Adv Hematol       Date:  2009-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.